Penz E, Rothe T, Dupont L, Tran TN, et al. Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2. Clin Exp Allergy 2025 Oct 29. doi: 10.1111/cea.70162.
PMID: 41162224